At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
FDA-approved GLP-1 receptor agonists produce 14.9 to 20.9% body weight loss in large randomized trials involving thousands of patients
Its important to take Semaglutide injections exactly as prescribed by your healthcare provider, and not to change your dose or frequency without first consulting with them
Representative KLOW titration at 3.0 mL reconstitution Volumes assume the standard 80 mg vial and 3.0 mL reconstitution
Currently, those with alcohol and substance use disorders (ASUDs) receive behavioural, motivational, and cognitive treatment, but the number of approved medications is somewhat limited